The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The genomics of young lung cancer.
 
Barbara J. Gitlitz
Consulting or Advisory Role - Clovis Oncology
Speakers' Bureau - Genentech/Roche; Lilly
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Novartis; Xcovery
 
Deborah Morosini
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Alicia L. Sable-Hunt
Consulting or Advisory Role - Fujirebio Diagnostics
 
Bonnie J. Addario
Stock and Other Ownership Interests - Celgene; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Medtronic
 
Stacy L. Mach
No Relationships to Disclose
 
Mark Byron Jennings
No Relationships to Disclose
 
S. Lani Park
No Relationships to Disclose
 
Marisa A Bittoni
No Relationships to Disclose
 
Geoffrey R. Oxnard
Honoraria - AstraZeneca; Chugai Pharma
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; Inivata; Sanofi; Sysmex
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)